CIK 0001642380 · Non-accelerated filer<br>Smaller reporting company
Insight Molecular Diagnostics Inc.
Sign in to watch- Ticker
- IMDX
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- CA
- Entity type
- operating
- EIN
- 271041563
- Phone
- 949-409-7600
- Business address
- 2 INTERNATIONAL PLAZA DR., SUITE 510, NASHVILLE, TN, 37217
- Former names
- OncoCyte Corp, Oncocyte Corp
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy 10% owner bought 2,420,000 shares at $2.92 ($7,057,688)
- 4 Open-market buy CEO and President bought 3,390 shares at $2.95 ($10,001)
- 4 Open-market buy Director bought 33,898 shares at $2.95 ($99,999)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Other disposition Former Director disposed of 3,085,047 shares (other)
- 4 Grant or award Director acquired 30,000 shares (grant or award)
- 4 Grant or award Director acquired 20,000 shares (grant or award)
- 4 Grant or award Director acquired 20,000 shares (grant or award)
- 4 Grant or award Director acquired 25,000 shares (grant or award)
- 4 Open-market buy Director bought 30,000 shares at $0.21 ($6,447)
- 4 Derivatives Options or other derivatives
- 4 Insider Changes in Ownership
- 4/A Other disposition 10% owner disposed of 3,890,111 shares (other)
- 4 Open-market buy 10% owner bought 663,000 shares at $0.30 ($200,027)
- 4 Open-market buy 10% owner bought 26,827,638 shares at $0.30 ($8,093,898)
Page 3 of 13 · 257 filings